BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33371825)

  • 1. Dose- and Time-Dependent Effects of Human Mesenchymal Stromal Cell Infusion on Cardiac Allograft Rejection in Mice.
    Wang F; Chen X; Li J; Wang D; Huang H; Li X; Bi Z; Peng Y; Zhang X; Li G; Wang J; Wang C; Fu Q; Liu L
    Stem Cells Dev; 2021 Feb; 30(4):203-213. PubMed ID: 33371825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.
    Casiraghi F; Azzollini N; Cassis P; Imberti B; Morigi M; Cugini D; Cavinato RA; Todeschini M; Solini S; Sonzogni A; Perico N; Remuzzi G; Noris M
    J Immunol; 2008 Sep; 181(6):3933-46. PubMed ID: 18768848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants.
    Khan MA; Alanazi F; Ahmed HA; Shamma T; Kelly K; Hammad MA; Alawad AO; Assiri AM; Broering DC
    Stem Cell Res Ther; 2019 Sep; 10(1):290. PubMed ID: 31547869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy.
    Qin YF; Kong DJ; Qin H; Zhu YL; Li GM; Sun CL; Zhao YM; Wang HD; Hao JP; Wang H
    Front Immunol; 2021; 12():672849. PubMed ID: 33995416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.
    Ge W; Jiang J; Baroja ML; Arp J; Zassoko R; Liu W; Bartholomew A; Garcia B; Wang H
    Am J Transplant; 2009 Aug; 9(8):1760-72. PubMed ID: 19563344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
    Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
    Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
    Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
    Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation.
    Casiraghi F; Todeschini M; Azzollini N; Cravedi P; Cassis P; Solini S; Fiori S; Rota C; Karachi A; Carrara C; Noris M; Perico N; Remuzzi G
    Transplantation; 2019 Jun; 103(6):1121-1130. PubMed ID: 30801518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of aryl hydrocarbon receptor prolongs survival of fully mismatched cardiac allografts.
    Cai LJ; Yu DW; Gao Y; Yang C; Zhou HM; Chen ZK
    J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):199-204. PubMed ID: 23592130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.
    Lee JH; Jeon EJ; Kim N; Nam YS; Im KI; Lim JY; Kim EJ; Cho ML; Han KT; Cho SG
    PLoS One; 2013; 8(8):e70968. PubMed ID: 23940676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice.
    Treacy O; Lynch K; Murphy N; Chen X; Donohoe E; Canning A; Lohan P; Shaw G; Fahy G; Ryan AE; Ritter T
    Stem Cell Res Ther; 2021 Apr; 12(1):227. PubMed ID: 33823917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of mesenchymal stem cells for the treatment of cardiac allograft rejection.
    Wu Z; Liang J; Huang W; Jiang L; Paul C; Gao X; Alam P; Kanisicak O; Xu M; Wang Y
    Exp Biol Med (Maywood); 2021 Apr; 246(7):851-860. PubMed ID: 33327780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1/IRF3-regulated-IFN-γ production.
    Chen Y; Yan G; Ma Y; Zhong M; Yang Y; Guo J; Wang C; Han W; Zhang L; Xu S; Huang J; Dai H; Qi Z
    Immunol Lett; 2021 Oct; 238():21-28. PubMed ID: 34228988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cardiac allograft rejection in mice using interleukin-35-modified mesenchymal stem cells.
    Wang W; Zhao N; Li B; Gao H; Yan Y; Guo H
    Scand J Immunol; 2019 Apr; 89(4):e12750. PubMed ID: 30664805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo allotransplantation engineering: Delivery of mesenchymal stem cells prolongs rejection-free allograft survival.
    Soares MA; Massie JP; Rifkin WJ; Rao N; Duckworth AM; Park C; Kadle RL; David JA; Rabbani PS; Ceradini DJ
    Am J Transplant; 2018 Jul; 18(7):1657-1667. PubMed ID: 29359512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinol suppresses cardiac allograft rejection in a murine model.
    Lu C; Zeng YQ; Liu H; Xie Q; Xu S; Tu K; Dou C; Dai Z
    J Heart Lung Transplant; 2017 Feb; 36(2):227-236. PubMed ID: 27574736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation.
    Lohan P; Murphy N; Treacy O; Lynch K; Morcos M; Chen B; Ryan AE; Griffin MD; Ritter T
    Front Immunol; 2018; 9():2666. PubMed ID: 30515159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Chimeric Recipient Precursor T Cells Promote Cardiac Allograft Survival in Mice.
    Lu L; Zhang G; Li R; Zhao Z; Li W; Liu T; Fu W
    Transplant Proc; 2015 Dec; 47(10):2978-84. PubMed ID: 26707325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment of transfused donor splenocytes and allografts with mitomycin C attenuates acute rejection in heart transplantation in mice.
    Liu L; Wang F; Zheng Y; Yuan X; Wang D; Zeng W; He X; Wang C; Deng S
    Transplant Proc; 2014 May; 46(4):1169-74. PubMed ID: 24815153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.